Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for Prevention of Paroxysmal Atrial Fibrillation
NCT00321802Phase 2Completed
- Sponsor
- University of Calgary
- Start
- Apr 2006
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin in Atrial fibrillation (AFib), sponsored by University of Calgary. Started Apr 2006; status: completed.
02
Drugs
simvastatin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00321802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321802.